Texas
Phase 1 cancer trials in Texas
406 Phase 1 cancer studies are recruiting participants at sites in 29 cities across Texas as of November 17, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Browse Texas by city
Cities with the most studies recruiting right now.
Houston
276 studies recruiting.
San Antonio
118 studies recruiting.
Dallas
100 studies recruiting.
Every Texas city with a recruiting study
By research area: Breast Cancer (127), Lung Cancer (127), Lymphoma (79), Prostate Cancer (37), Pancreatic Cancer (19), Melanoma (17).
Houston (276), San Antonio (118), Dallas (100), Austin (32), Irving (31), Fort Worth (24), Tyler (12), El Paso (3), Lubbock (3), Sugar Land (3), Amarillo (2), Conroe (2), Laredo (2), League City (2), Abilene (1), Austin, TX 78758 (1), Bedford (1), Corpus Christi (1), Flower Mound (1), Galveston (1), Garland (1), Nashville (1), Pearland (1), Plano (1), Richardson (1), Round Rock (1), The Woodlands (1), Waco (1), Woodland (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Texas
Basic details from each study's public record (the 12 most recently updated of 406). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Totus Medicines
- Recruiting in
- Flower Mound
- Registry record
- NCT05683418 · updated
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Recruiting in
- Austin · Dallas · Houston
- Registry record
- NCT06253871 · updated
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Recruiting in
- Houston
- Registry record
- NCT07020117 · updated
Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Recruiting in
- Houston
- Registry record
- NCT07553390 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Texas on ClinicalTrials.gov.
Lung cancer: recently updated in Texas
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Vivace Therapeutics, Inc
- Recruiting in
- Houston · San Antonio
- Registry record
- NCT04665206 · updated
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Recruiting in
- Houston · San Antonio
- Registry record
- NCT05786924 · updated
A Study of VET3-TGI in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- KaliVir Immunotherapeutics
- Recruiting in
- Dallas · Houston
- Registry record
- NCT06444815 · updated
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- EpiBiologics
- Recruiting in
- Houston · San Antonio
- Registry record
- NCT07462377 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Texas on ClinicalTrials.gov.
Prostate cancer: recently updated in Texas
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Astellas Pharma Global Development, Inc.
- Recruiting in
- Houston
- Registry record
- NCT05997615 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Texas on ClinicalTrials.gov.
Lymphoma: recently updated in Texas
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Recruiting in
- Austin · Corpus Christi · Dallas · and 5 more U.S. locations
- Registry record
- NCT04726241 · updated
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Debiopharm International SA
- Recruiting in
- Dallas · Houston · San Antonio
- Registry record
- NCT05765812 · updated
A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Hepatic Impairment
- Phase 1
- Ages 18 to 80
- All sexes
- Sponsor
- Incyte Corporation
- Recruiting in
- San Antonio
- Registry record
- NCT07853040 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Texas on ClinicalTrials.gov.
Ask about studies in Texas
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections